Predicting daytime sleepiness and fatigue: a 9-year prospective study in myotonic dystrophy type 1

被引:23
作者
Laberge, Luc [1 ,2 ,3 ,4 ,5 ]
Gallais, Benjamin [1 ,3 ,4 ,5 ]
Auclair, Julie [1 ]
Dauvilliers, Yves [6 ]
Mathieu, Jean [3 ,4 ,5 ]
Gagnon, Cynthia [3 ,4 ,5 ]
机构
[1] Cegep Jonquiere, ECOBES Rech & Transfert, 2505 Rue St Hubert, Jonquiere, PQ G7X 7W2, Canada
[2] Univ Quebec Chicoutimi, Dept Sci Sante, 555 Boul Univ, Chicoutimi, PQ G7H 2B1, Canada
[3] Univ Sherbrooke, Ecole Readaptat, Fac Med & Sci Sante, Sherbrooke, PQ, Canada
[4] Ctr Integre Univ Sante & Serv Sociaux Saguenay La, GRIMN, Jonquiere, PQ, Canada
[5] Univ Sherbrooke, Ctr Rech Charles Le Moyne, Ctr Integre Univ Saguenay Lac St Jean Innovat, Jonquiere, PQ, Canada
[6] Hop Gui de Chauliac, Dept Neurol, INSERM U1061, 80 Ave Augustin Fliche, F-34295 Montpellier 5, France
基金
加拿大健康研究院;
关键词
Myotonic dystrophy; Daytime sleepiness; Fatigue; Prospective; Longitudinal; Linear mixed-effects regression model; ALVEOLAR HYPOVENTILATION; ENDOCRINE FUNCTION; REPEAT LENGTH; CTG REPEATS; HYPERSOMNIA; EXPANSION; SCALE; APNEA; AGE; INVOLVEMENT;
D O I
10.1007/s00415-019-09592-7
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
ObjectiveDaytime sleepiness and fatigue are prominent symptoms of myotonic dystrophy type I (DM1) that exact a heavy toll on patients' quality of life, but information is scarce on their predictive factors. This study aimed to determine factors that may influence levels of daytime sleepiness and fatigue in a large cohort of DM1 patients followed for 9 years.MethodsThis study included 115 patients with DM1 at baseline (Time 1, T1) and at Time 2 (T2) who were questioned for daytime sleepiness, fatigue, history of depression, psychological distress, pain, hypothyroidism, and sleep habits. Also, their muscular impairment and intellectual quotient were evaluated. Regression models were used to identify correlates of daytime sleepiness and fatigue while controlling for time effect.ResultsBoth daytime sleepiness and fatigue increased between T1 and T2, but their rate of change are higher when CTG repeat number is higher (p<0.05). Also, higher psychological distress level is associated with higher daytime sleepiness and fatigue levels both at T1 and T2 (p<0.01). Moreover, patients with a history of depression report higher daytime sleepiness levels both at T1 and T2 (p<0.05). In addition, patients with higher fatigue levels both at T1 and T2 have more severe muscular impairment (p<0.01) and report a longer habitual sleep duration (p<0.05). Finally, a higher BMI and a history of hypothyroidism predict higher daytime sleepiness levels at T2 (p<0.05).ConclusionThis study identified potentially modifiable risk factors of future daytime sleepiness and fatigue in DM1 patients, including BMI, psychological distress, hypothyroidism, and sleep habits.
引用
收藏
页码:461 / 468
页数:8
相关论文
共 62 条
[1]   Myotonic dystrophy as a brain disorder [J].
Ashizawa, T .
ARCHIVES OF NEUROLOGY, 1998, 55 (03) :291-293
[2]   Psychological characteristics of patients with myotonic dystrophy type 1 [J].
Bertrand, J. A. ;
Jean, S. ;
Laberge, L. ;
Gagnon, C. ;
Mathieu, J. ;
Gagnon, J. F. ;
Richer, L. .
ACTA NEUROLOGICA SCANDINAVICA, 2015, 132 (01) :49-58
[3]   Excessive daytime sleepiness in a general population sample: The role of sleep apnea, age, obesity, diabetes, and depression [J].
Bixler, EO ;
Vgontzas, AN ;
Lin, HM ;
Calhoun, SL ;
Vela-Bueno, AV ;
Kales, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (08) :4510-4515
[4]  
Chaudhry N, 2016, J INDIAN ACAD CLIN M, V17, P40
[5]   Sleepiness, fatigue, tiredness, and lack of energy in obstructive sleep apnea [J].
Chervin, RD .
CHEST, 2000, 118 (02) :372-379
[6]   ALVEOLAR HYPOVENTILATION AND HYPERSOMNIA IN MYOTONIC-DYSTROPHY [J].
COCCAGNA, G ;
MANTOVANI, M ;
PARCHI, C ;
MIRONI, F ;
LUGARESI, E .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1975, 38 (10) :977-984
[7]   Endocrine function over time in patients with myotonic dystrophy type 1 [J].
Dahlqvist, J. R. ;
Orngreen, M. C. ;
Witting, N. ;
Vissing, J. .
EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 (01) :116-122
[8]  
Dauvilliers Yves A, 2012, Sleep Med Rev, V16, P539, DOI 10.1016/j.smrv.2012.01.001
[9]  
Dement WC, 2003, SLEEP, V26, P485
[10]  
DEROGATIS L R, 1973, Psychopharmacology Bulletin, V9, P13